Sort
172,184 grants matching “inflammation”
Decoding in vivo regulatory programs of CD4+ T lymphocyte populations in inflamma
$1,033,344Christina S Leslie · Sloan-Kettering Inst Can Research · U01 · FY2016 · HG
Tissue and organ specific human B cell immunity: Supplement - Metabolic Risk Factors and Inflammation in PASC Development
$1,033,284Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2022 · AI
GuMI: New In Vitro Platforms to Parse the Human Gut Epithelial-Microbiome-Immune Axis
$1,033,277Rebecca L Carrier · Northeastern University · R01 · FY2016 · EB
Inflammatory molecules in radiation risk assessment: preclinical drug testing
$1,033,167Paul Okunieff · University Of Rochester · U19 · FY2007 · AI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?
$1,033,116Evan D Morris · Yale University · R01 · FY2023 · DA
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease
$1,032,520Eva L Feldman · University Of Michigan At Ann Arbor · U01 · FY2019 · AG
Epithelial Genes In Allergic Inflammation
$1,032,432Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2008 · AI
Developmental Continuity Of Individual Differences In Reactivity In Monkeys
$1,032,356Stephen J. Suomi · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Cell-type based epigenomic analysis to identify druggable genes for people living with HIV infection and using cannabis
$1,032,192Ke Xu · Yale University · R01 · FY2024 · DA
Immunity to Pneumonic Tularemia
$1,032,095Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
CIP Genomics Core
$1,032,059Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Viral Vector Core
$1,032,048Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2020 · ES
Xenobiotic receptors
$1,031,958Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Sulfated Non-Anticoagulant Heparin Nanoparticle (VVP728) for Sickle Cell Disease Management
$1,031,733Bozena Korczak · Vascular Vision Pharmaceuticals Company · R44 · FY2024 · HL
Therapeutic Human Monoclonal Antibodies Against Staphylococcal Enterotoxin B (SEB
$1,031,598M. Javad Aman · Integrated Biotherapeutics, Inc. · U01 · FY2009 · AI
Mechanisms of Ischemic Neonatal Brain Injury
$1,031,557Donna M. Ferriero · University Of California, San Francisco · P50 · FY2009 · NS
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
$1,031,346Daniel William Cramer · Brigham And Women'S Hospital · R35 · FY2017 · CA
Effect of Tart Cherry Supplementation on Vascular Health in Healthy Older Adults
$1,031,323Mary Engler · National Institute Of Nursing Research · ZIA · FY2013 · NR
Mediterranean Dietary Intervention in Pediatric Hyperlipidemia
$1,031,323Marguerite Engler · National Institute Of Nursing Research · ZIA · FY2013 · NR
Effects of Dietary Blackcurrant Extract and PCSO-524
$1,031,323Marguerite Engler · National Institute Of Nursing Research · ZIA · FY2013 · NR
AdaptiSPECT-C: A Next-Generation, Adaptive Brain-Imaging SPECT System for Drug Discovery and Clinical Imaging
$1,031,218Michael A King · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · EB
Clinical Outcomes in Rehabilitated Burn Children
$1,031,147David N Herndon · University Of Texas Med Br Galveston · P50 · FY2008 · GM
The Human Life Course and the Biodemography of Aging
$1,031,138Michael Douglas Gurven · University Of California Santa Barbara · R01 · FY2013 · AG
Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease
$1,030,857Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Sulfated Non-Anticoagulant Heparin Nanoparticle (VVP728) for Sickle Cell Disease Management
$1,030,837Bozena Korczak · Vascular Vision Pharmaceuticals Company · R44 · FY2023 · HL